• Quinkert, G. et al., Annalen, 1981, 2335; 1982, 1999, (synth)
• Collins, M.A. et al., Tet. Lett., 1995, 36, 4467, (synth)
• Larner, J.M. et al., Endocrinology (Baltimore), 1985, 117, 1209, (metab)
• Aldrich Library of 13C and 1H FT NMR Spectra, 1992, 3, 565A; 589B; 600B, (nmr)
• Marker, R.E., J.A.C.S., 1938, 60, 2927, (synth)
• Salole, E.G. et al., Anal. Profiles Drug Subst., 1986, 15, 283, (rev)
• Martindale, The Extra Pharmacopoeia, 32nd edn., Pharmaceutical Press, 1999, 1455
• Tsukuda, Y. et al., J.C.S.(B), 1968, 1387, (cryst struct)
• Wittstruck, T.A. et al., J.O.C., 1973, 38, 1542, (cmr)
• Ponold, K. et al., Pharmazie, 1973, 28, 371; 1977, 32, 598; 1979, 34, 2050, (STS 153)
• Busetta, B. et al., Acta Cryst. B, 1976, 32, 1290, (cryst struct)
• Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, BFV325; EDO000; EDP000; EDR000; EDS100; DAZ115; EDO500; EDR500
• Aldrich Library of FT-IR Spectra, 1st edn., 1985, 2, 1055C, (ir)
• IARC Monog., 1979, 21, 279, (tox, rev)
• Hylarides, M.D. et al., J.O.C., 1984, 49, 2744, (synth)
• Ohrt, J.M. et al., Acta Cryst., 1964, 17, 1611, (cryst struct, derivs)
• Eder, U. et al., Chem. Ber., 1976, 109, 2948, (synth)
• Negwer, M., Organic-Chemical Drugs and their Synonyms, 7th edn., Akademie-Verlag, 1994, 6627, (synonyms)
• Schneider, G. et al., Annalen, 1988, 679, (3-Me ether, synth, pmr, cmr, ir)
• Miki, T. et al., Proc. Chem. Soc., London, 1963, 139, (synth)
• Gibson, H. et al., Tet. Lett., 1966, 2321, (synth)